This pilot research trial studies biomarkers in bone marrow samples from pediatric patients with high risk acute myeloid leukemia. Studying samples of bone marrow from patients with cancer in the laboratory may help doctors identify and learn more about biomarkers related to cancer.
Age range
21 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Detailed molecular map of pediatric high-risk acute myeloid leukemia
Timeframe: Baseline
Mutations in identifying novel changes associated with pediatric AML
Timeframe: Baseline
Expression profile in identifying novel changes associated with pediatric AML
Timeframe: Baseline
Gene copy number in identifying novel changes associated with pediatric AML
Timeframe: Baseline
LOH status in identifying novel changes associated with pediatric AML
Timeframe: Baseline
Genomic methylation patterns in identifying novel changes associated with pediatric AML
Timeframe: Baseline
Genomic and transcriptome alterations associated with induction failure
Timeframe: Baseline
Genomic alterations contributing to induction failure in childhood AML
Timeframe: Baseline